Background: Lamotrigine (LTG) and levetiracetam (LEV) are widely and increasingly prescribed second generation antiepileptic drugs for women with epilepsy during childbearing age. However, data pertaining to their congenital malformations are lacking. Aim: This study aimed to investigate and compare the teratogenic effects of LTG and LEV on normal adult female albino rats and their fetuses in order to find out the least teratogenic one of them. Materials and methods: Ninety-six adult albino rats (64 virgin females and 32 males) of almost the same range of weight and age were used. Pregnant rats were divided into 4 groups. The 1 st group (control; received 1 ml of distilled water) and the 2 nd group (vehicle; received 1 ml of 2% Arabic gum), while the 3 rd (LTG-treated) and 4 th (LEV-treated) groups received 50 mg/kg/b.wt. of LTG and 310 mg/kg/b.wt. of LEV, respectively. All substances were administered as single oral dose starting from gestational day (GD) 7 to 15. On GD 20, all dams were weighted then sacrificed and subjected to Cesarean section. The total numbers of ovarian corpora lutea and the status of all implantation sites (the total numbers of resorption sites, live and dead fetuses, and the total implantations) were counted. The gravid uteri were subsequently removed, weighted, and fetuses were delivered. The fetuses' numbers, weights, different body lengths, gross abnormalities, and skeletal malformations were recorded. Results: On GD 20, maternal weight gains and gravid uteri weights were statistically significantly lower in both treated groups than control and these differences were more significant in LTG than LEV. The percentages of pre-implantation and post-implantation losses in LTG and LEV exhibited statistically significant increase and non-significant differences compared with control, respectively, and the latter was more pronounced in LTG than LEV. As regard the numbers, weights, crown-rump lengths, biparietal diameters and head lengths of the fetuses, both treated groups showed significant differences in comparison to the control with higher abnormalities in LTG-treated than LEV-treated groups. Fetuses from treated groups revealed various gross abnormalities in the internal organs. Fetuses' skeletons examination revealed bone defects in both treated groups. Skull, vertebrae, and hind limb skeletal malformations were more prevalent in LTG-treated group, while sternum was more affected in LEV-treated group. Conclusion: Both antiepileptic drugs were teratogenic in variable degrees; however, LEV appears to be less teratogenic than LTG.
INTRODUCTION
Epilepsy is one of the most prevalent neurological diseases and its spread depends on age, racial, social class, as well as geographic and national boundaries.
It affects approximately 50 million people all over the world; 2 millions of them were recorded in the United States (ElSayyad et al., 2013). Patients with epilepsy who become pregnant are at risk of complications, including changes in seizure frequency, maternal morbidity and mortality, and congenital anomalies due to antiepileptic drug exposure (Borgelt et al., 2016) .
Management of pregnant women with epilepsy is problematic as seizures need to be prevented because they clearly increase the risk of maternal and foetal injury, miscarriage, epilepsy in the offspring, and developmental delay. On the other hand, foetal exposure to antiepileptic drugs is associated with increased risk of congenital malformation, congenital anomalies, intrauterine growth retardation, and neonatal haemorrhage. Physicians mostly encounter the problem of choosing monotheraphy with minimal teratogenic effect, plus adequate seizure control in pregnant woman with epilepsy (Ozer et al., 2012).
Reproductive-aged women with epilepsy may present a number of specific issues to be managed in daily clinical practice. The impact of epileptic seizures and antiepileptic therapy on pregnancy outcome and the risk of teratogenicity should be minimized, which require careful attention and cooperation between obstetric gynecologyst and neurologist. There is evidence that certain antiepileptic drugs (AEDs) are teratogenic and are associated with an increased risk of congenital malformation. The majority of women with epilepsy continue taking AEDs throughout pregnancy; therefore it is important that comprehensive information on the potential risks associated with AED treatment is available (Vanya et al., 2016) .
The first generation antiepileptic drugs like phenytoin, carbamazepine and sodium valproate are widely used but they have increased risk of adverse reactions and drug interactions and require therapeutic monitoring (Landmark and Patsalos, 2010). Therefore, the second generation drugs are preferred due to favourable side effect profile and less chance of drug interactions (Perucca, 2002) .
Lamotrigine (LTG), a secondgeneration antiepileptic agent of phenyltriazine derivatives, is most widely used for treatment of both partial and generalised seizures. On the other hand, its use in pregnancy is associated with risk of seizure deterioration because its clearance is accelerated in pregnancy. This reveals the need of additional information on the therapeutic window of LTG and its possible toxic effects in pregnancy (Sathiya et al., 2014) . Although LTG monotherapy during pregnancy is assumed to be relatively safe, its teratogenic effects has been reported previously (Degirmencioglu et al., 2016).
Levetiracetam (LEV) is a broadspectrum AED which is currently licensed in the United States and the United Kingdom and Ireland for use as adjunctive treatment of focal-onset seizures and myoclonic seizures or generalized tonic-clonic seizures, occurring as part of generalized epilepsy syndromes. In the United Kingdom and Ireland, it is also licensed as monotherapy treatment for focalonset seizures. Previous small studies have suggested a low risk for major congenital malformations (MCM) with LEV use in pregnancy (Mawhinney et al., 2013) .
Exposure to LTG and LEV carried the lowest risk of overall malformation; however, data pertaining to specific malformations are lacking. Physicians should discuss both the risks and treatment efficacy with the patient prior to commencing treatment (Weston et al., 2016) .
The aim of this study was to investigate and compare the teratogenic effects of the second generation antiepileptic drugs LTG and LEV on normal adult pregnant female albino rats and their fetuses, in order to find out the safest and the least teratogenic one of them.
MATERIALS & METHODS

Tested Drugs and Dosage
Regimen:
Lamotrigine (LTG), 50-mg tablets, was obtained from Multi-Apex Company; they are white, rounded, and compressed tablets. Levetiracetam (LEV), 500-mg film-coated tablets purchased from Sigma for Pharmaceutical Industries (S.P.I), for Al Andalus Medical Company. The administered doses were 50 mg/kg/b.wt. for LTG and 310 mg/kg/b.wt. for LEV and chosen according to Sarangi et al. (2016) . All doses were suspended in freshly prepared 2% Arabic gum (acacia gum) to obtain the necessary concentration of each drug in 1 ml. The dosage volumes for animals were calculated according to their daily body weights.
Animals:
Ninety-six adult albino rats were used in this study (64 virgin females and 32 males of almost the same range of weight and age). th day of gestation (one day before the expected date of delivery to prevent the mothers from devouring any damaged offspring), all pregnant rats were sacrificed by cervical decapitation under ether anesthesia then subjected to Cesarean section. All ovaries were examined using a magnifying lens and the total numbers of corpora lutea (appearing large and yellowish tinge in color) were counted. All gravid uteri were carefully inspected and the status of all implantation sites were recorded (i.e. the total numbers of resorption sites, live and dead fetuses, and the total implantations).
Resorptions were determined as early (dark brown blood spot with just placental tissue) and late (large blood clot attached to the uterine wall with placental and embryonic tissue). The gravid uteri were harvested after cutting of the mesometrium, mesovarium, and vagina then uterine horns were cut longitudinally very gently with the tip of blunt scissor to deliver fetuses. Each live fetus was washed with normal saline then dried on a bloating paper. The numbers and weights the fetuses (live or dead) were recorded. The fetuses' crown rump length, head length, and biparietal diameter were measured using a calibrated metallic gauge. Additionally, using a magnifying lens each fetus was carefully examined for any apparent external gross abnormality in an ordinary manner from the head to the tail.
After recording all measurements and parameters, fetuses from each group were equally divided into two groups. The first group was fixed in Bouin's solution for efficient decalcification in order to allow easier performance of free hand serial sections in the soft fetal tissues, while the second group was prepared for skeletal examination.
The percentage of pre-implantation loss was calculated as: [(total number of corpora lutea ˗ total number of implantation sites) / total number of corpora lutea] x 100. The percentage of post-implantation loss was calculated as: [(total number of implantation sites ˗ total number of live embryos) / total number of implantation sites] x 100.
Razor sections preparation According to Kotb (1973) , serial sections of 1mm thickness were performed at different landmarks and levels along the fetuses' bodies that were examined under the magnification of the binocular dissecting microscope for the presence of any gross abnormalities in the internal organs. The collected data were tabulated and analyzed using SPSS version 16 software (SPSS Inc, Chicago, IL Company) .
Categorical data were presented as number and percentages while quantitative data were expressed as mean and standard deviation. The one-way analysis of variance (ANOVA) and Z-test were used as test of significance. Significant ANOVA was followed by post hoc multiple comparisons using Bonferroni to detect significant pairs. The accepted level of significance was stated at 0.05 (P <0.05 was considered significant). In addition, the statistical differences of the mean values regarding offspring/dam, CRL, BPD, and HL variables were significantly lower in LTG group (p<0.05) than LEV group with the exception of body weight, which showed non-significant differences (p>0.05) between both groups. Table ( 3) shows the incidence of external and internal gross morphological abnormalities in fetuses from dams administrated LTG and LEV. The proportions of hematomas (55.56% vs 0.00%) as well as brain (44.44% vs 7.69%), heart (38.89% vs 0.00%), and lung (27.78% vs 0.00%) abnormalities were higher in fetuses of LTG-treated group than LEV-treated group, while liver (53.85% vs 11.11%) and stomach (46.15% vs 11.11%) abnormalities were higher in fetuses of LEV-treated group than LTG-treated group.
RESULTS
There were statistically significant differences (p<0.05) between both groups regarding the aforementioned variables.
Table (4) summarizes the incidence of skeletal malformations in fetuses from dams administrated LTG and LEV. The proportions of skull (100% vs 47.6%), vertebra (100% vs 38%), and hindlimb (87.5% vs 38%) malformations were higher in fetuses of LTG-treated group than LEV-treated group, whereas sternal defect (47.6% vs 12.5%) was higher in fetuses of LEVtreated group than LTG-treated group. There were statistically significant differences (p<0.05) between both Although the proportion of forelimb defect (25% vs 14.3%) was higher in LTG-treated than LEV-treated dams and the proportions of ribs (23.8% vs 18.75%) and metacarpal and metatarsal (28.6% vs 18.75%) defects were higher in LEV-treated than LTGtreated dams, however, the statistical comparison between both groups regarding these parameters showed non-significant differences (p>0.05).
External gross morphological examination ( Fig. 1 to 9 )
Normal corpus lutea of pregnancy appears yellowish tinge in color and normal pregnant uterus with live fetuses and without resorption sites among control group ( Fig.1 and 2) .
Pregnant rats treated with LTG exhibited empty uterine horns with dark brown spots (indicating early postimplantation loss) and large blood clots (indicating sites of late postimplantation resorption) ( Fig. 3 and 4) .
With respect to the external features of the fetuses obtained from control, LTG, and LEV treated mothers, no severe morphological alterations were observed. However, fetal growth retardation was the main change observed and the shortest fetal CRL was noticed in the LTG-treated dams, followed by LEV-treated dams in comparison with the control fetus (Fig.  5) . Also, a fetal back hematoma was recorded secondary to administration of LTG to dams (Fig. 6) .
Razor sections at different levels revealed gross abnormalities in the internal organs in different groups. At the level of the largest transverse diameter of the head ( Fig. 7 and 8) , fetal bilaterally dilated lateral ventricles, cardiac defects, and malformed lungs were observed in LTG-treated group. While at the level of the abdominal region just above the umbilicus, the fetus from LEV-treated group showed hemorrhagic liver spots and shrunken stomach (Fig.9 ). Skeletal examination (Fig. 10 to 
19)
Alizarin red stain was used to detect skeletal deformities of the fetuses. The completely ossified bones take the stain completely and appear red in colour, incompletely ossified bones partially take the stain and appear lightly stained. However, non-ossified bones don't take the stain completely.
The skeletal system of the rat consists of two main groups; the axial skeleton and appendicular skeleton. The axial skeleton comprises bones of the skull, vertebral column, ribs and sternum, while the appendicular skeleton consists of bones of pectoral girdle and fore limbs, pelvic girdle and hind limbs. In the fetuses of control group most of the bones were normally ossified (Fig. 10) .
The Skull (Fig. 11-13 ):
The skull elements of the control fetuses are in a good ossified condition. The vault (nasal, frontal, parietal, interparietal, and supraoccipital) (Fig.  11A) , the basal skull (premaxilla, maxilla, palatine, zygomatic, presphenoid, basisphenoid, squamosal, tympanic bulla, basioccipital, exooccipital, supraoccipital) (Fig. 12A) , and the mandibular bones (Fig. 13A ) appeared well ossified.
In LTG-treated group, the degree of ossifications of the fetuses' skull bones was moderately to severely affected as compared to the control fetuses. Fetuses of LTG-treated mothers showed partial or delayed ossification of frontal, parietal (Fig. 11B) , zygomatic, palatine, presphenoid, basisphenoid, basioccipital, exooccipital (Fig. 12B) , and mandibular (Fig. 13B ) bones as well as absent ossification of nasal, interparietal, supraoccipital (Fig. 11B) , premaxilla, maxilla, tympanic bulla, and squamosal bones (Fig. 12B) .
In LEV-treated group (Fig. 11C,  12C , and 13C), the degree of ossifications of the fetuses' skull bones were mildly to moderately affected as compared to the control fetuses. The most obvious findings were delayed ossification of almost skull bones (Fig.  11C ) with complete absence of ossification of interparietal (Fig. 11C ) and exooccipital (Fig. 12C) bones.
The Vertebral Column (Fig. 10C  and 14) :
The vertebral column of control fetuses consists of well ossified vertebrae which are represented by 7 cervical, 12 thoracic, 7 lumber, 4 sacral and at least 10 caudal vertebrae with clearly ossified body and arches (Fig.  10C) .
In LTG-treated group, fetal vertebral column showed vertebral dislocation (due to absence and delayed ossification of thoracic and lumbar vertebrae centers), caudal regression (due to delayed centra and absent ossification of upper sacral arches and centra) (Fig. 14A) , and vertebral scoliosis (Fig. 14B) .
On the other hand, mild effects on fetal vertebral bodies with partial ossification of lumbar and sacral bones were noticed in LEV-treated group (Fig. 14C) .
Ribs (Fig. 15) :
The control fetuses possess 13 pairs of ribs with well ossified vertebral portions and the sternal portions of ribs appear cartilaginous in nature (Fig.  15A ).
The ribs of fetuses obtained from mothers treated with LTG and LEV showed no variations in number and in the ossified condition compared to the control. However, fusion of two or more fetal ribs in LTG-treated group (Fig. 15B) and missed fetal ribs in LEV-treated group (Fig. 15C) were observed.
Sternebrae (Fig. 16) : Most of the control fetuses possess 6 parts of well ossified sternebrae and the last one of them is the xiphisternum (Fig. 16A) . The sternebrae obtained from fetuses of LTG-treated and LEVtreated dams were, respectively, slightly ( Fig. 16B ) and severely (shorter than normal control with only 3 or 4 sternebrae) (Fig. 16C) affected.
The pectoral girdle and forelimb (Fig. 17) :
The pectoral girdle of the control fetuses comprised a well ossified scapula and clavicle. The forelimb components were the ossified scapula, humerus, radius, ulna, metacarpal bones and phalanges (Fig. 17A) . In LTGtreated mothers, the degree of ossification of the fetal scapula, humerus, radius and ulna were slightly affected with absent ossification of metacarpal bones (Fig. 17B) . In LEVtreated dams, the fetus showed nearly complete ossification of all forelimb bones, except for delayed development of metacarpal bones (Fig. 17C) .
The pelvic girdle and hind limb (Fig. 18 and 19) :
The pelvic girdle of the control fetus consists of three well ossified bones; ilium, ischium and pubis and the hind limb consists of well ossified femur, tibia, fibula bones, series of phalanges in the four digits, and cartilaginous tarsals and metatarsals (Fig.18A) . The fetal pelvic girdle obtained from LTG-treated mothers showed incomplete ossification of ilium, ischium, femur, tibia, and fibula and absent ossification of metatarsal bones as well as mild to moderate caudal dysgenesis (manifested by shortage in length of the components of the pelvic girdle with absence of caudal vertebrae) ( Fig.18B and 19A) .
While fetal pelvic girdle of LEVtreated mothers showed nearly complete ossification of all pelvic girdle and hindlimb bones as well as partial ossification of lacrimal, frontal, maxilla, mandibular, metacarpal, and metatarsal bones (Fig.18C and 19B) . compared to control group; @=Non-significant difference compared to vehicle group; #=Non-significant difference between LTG and LEV treated groups; NaN=Not a number (0.0); *=Significant difference compared to control group; &=Significant difference compared to vehicle group; $=Significant difference between LTG and LEV treated groups. Data shown as mean ± standard deviation; P-value of >0.05 is considered non-significant; P-value of <0.05 is considered significant. In the current study, Arabic gum had negative effects on fetuses' development and no teratogenic responses were seen. Similarly, numerous other studies that were conducted in experimental animals did not reveal any teratogenic potential of Arabic gum ( (2008) found that pregnant rats treated with LTG (at lower doses than this study) and LEV had no effect on maternal weight gain. This decrease in maternal body weight gain may be attributed to decrease in food and water intake (Sathiya et al., 2014) and/or intrauterine growth retardation (Padmanabhan et al., 2003) .
In this study, the weight of gravid uteri of LTG and LEV groups were statistically lower than the control group and this difference was statistically significantly lower in LTG group than LEV group. Also, preimplantation loss and post-implantation loss and resorption in LTG-treated dams and those in LEV-treated dams were significantly high and insignificantly different, respectively, as compared with control and postimplantation loss and resorption was statistically higher in LTG group than showed that LTG administration increased the follicle stimulating hormone and luteinizing hormone which in turn stimulated estrogen secretion. Increased estrogen secretion results in maturation of graaffian follicle followed by ovulation which leads to embryo detachment. This may be the possible reason for the observed resorbed fetuses.
As regard the weight, crown-rump length, biparietal diameter, and head length of the fetuses, this study revealed that both treated groups have significant decreases in comparison to the control, with more reduction in the mean values of LTG than LEV-treated groups. These findings are in agreement with the results of several authors who reported significant reductions in body weight and dimensions in fetuses from dams exposed to LTG ( Reduced maternal food and water intake might had some influence on the fetal outcome but data on maternal food restriction or short episodes of starvation during gestation in rats and rabbits indicate that this may be the case as regards to increased resorption or growth retardation but not fetal malformations (Petrere et al., 1993;  Padmanabhan et al., 2003) .
Regarding external examination in the present work, hematomas were detected in LTG-treated group, while not observed in LEV-treated group. These results go in hand with Mohanty et al. (2011), who demonstrated that the offsprings of LTG-treated rat had hemorrhages over the body in some of these fetuses. Also, in a mouse model of teratogenicity, no gross external malformations were observed in offspring prenatally exposed to LEV (Isoherranen et al., 2003) . On the other hand, El-Ghareeb et al. (2015) found that LEV caused gross subcutaneous hematoma in albino rat fetuses during pregnancy.
The literatures concerning the teratogenic effects of LTG and LEV in humans are controversial. In various epidemiological studies, the rate of major congenital malformations (MCM) regarding LTG monotherapy during pregnancy ranged between 1.4%-5.2% ( In the present study, gross anomalies were present in both treated groups. The anomalies found in LTGtreated groups were dilatation of lateral ventricles, cardiac defects, and malformed lungs, while the abnormalities in LEV-treated group were hemorrhagic liver spots and shrunken stomach. Correspondingly, in other experimental researches neuronal alterations like ventricle dilatation, enhancement of subcortical density, increase in cerebral volume and diameter were associated with administration of LTG to pregnant animals during the organogenesis period (Isoherranen et al., 2003) .
In the present study, staining the skeletons of the rat fetuses by alizarin red stain revealed that both treated 
